Latest Insider Transactions at Cidara Therapeutics, Inc. (CDTX)
This section provides a real-time view of insider transactions for Cidara Therapeutics, Inc. (CDTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cidara Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cidara Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2021
|
Neil Abdollahian Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,469
-2.49%
|
$2,938
$2.66 P/Share
|
|
Mar 31
2021
|
Jeffrey Stein President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+2.69%
|
-
|
|
Mar 31
2021
|
Taylor Sandison Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
700
+0.85%
|
-
|
|
Mar 31
2021
|
Jessica Oien General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+23.85%
|
-
|
|
Mar 31
2021
|
Paul Daruwala Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+2.67%
|
-
|
|
Mar 31
2021
|
Neil Abdollahian Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+5.61%
|
-
|
|
Jan 05
2021
|
Jessica Oien General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
824
-11.83%
|
$1,648
$2.06 P/Share
|
|
Jan 05
2021
|
Paul Daruwala Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,868
-5.45%
|
$5,736
$2.06 P/Share
|
|
Jan 05
2021
|
Neil Abdollahian Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,868
-4.92%
|
$5,736
$2.06 P/Share
|
|
Dec 10
2020
|
Jeffrey Stein President & CEO |
SELL
Other acquisition or disposition
|
Indirect |
658
-31.33%
|
-
|
|
Nov 10
2020
|
Jeffrey Stein President & CEO |
BUY
Open market or private purchase
|
Indirect |
2,500
+3.48%
|
$100,000
$40.01 P/Share
|
|
Nov 10
2020
|
Jeffrey Stein President & CEO |
SELL
Other acquisition or disposition
|
Direct |
2,500
-30.26%
|
$100,000
$40.01 P/Share
|
|
Nov 10
2020
|
James E. Levine Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
50,000
+50.0%
|
$100,000
$2.01 P/Share
|
|
Nov 10
2020
|
Jeffrey Stein President & CEO |
BUY
Open market or private purchase
|
Direct |
50,000
+12.57%
|
$100,000
$2.0 P/Share
|
|
Sep 12
2017
|
Jeffrey Stein President & CEO |
BUY
Open market or private purchase
|
Indirect |
367
+0.55%
|
$49,545
$135.8 P/Share
|
|
Sep 12
2017
|
Jeffrey Stein President & CEO |
SELL
Other acquisition or disposition
|
Direct |
367
-4.25%
|
$49,545
$135.8 P/Share
|
|
Jun 05
2017
|
Jeffrey Stein President & CEO |
BUY
Open market or private purchase
|
Indirect |
750
+1.12%
|
$88,500
$118.95 P/Share
|
|
Jun 05
2017
|
Jeffrey Stein President & CEO |
SELL
Other acquisition or disposition
|
Direct |
750
-8.0%
|
$88,500
$118.95 P/Share
|
|
Mar 31
2017
|
Jeffrey Stein President & CEO |
BUY
Open market or private purchase
|
Indirect |
645
+0.97%
|
$99,975
$155.0 P/Share
|
|
Mar 31
2017
|
Jeffrey Stein President & CEO |
SELL
Other acquisition or disposition
|
Direct |
645
-6.43%
|
$99,975
$155.0 P/Share
|
|
May 23
2016
|
Jeffrey Stein President & CEO |
SELL
Other acquisition or disposition
|
Direct |
270
-2.62%
|
-
|